Parkinson's disease is notoriously difficult to diagnose because it relies primarily on the onse

Targeting a parasite's DNA could be a more effective way to combat malaria, new research from th

2022.04.06, Novartis announced that the U.S. Food and Drug Administration (FDA) has granted accelera

Bristol-Myers Squibb (BMS) recently announced positive results from the Phase 2 PAISLEY study (NCT03

Takeda announced the Phase 3 SHP643 to evaluate the safety and pharmacokinetics of Takhzyro (lanadel

Recently, Bristol-Myers Squibb (BMS) presented 2-year data from the POETYK PSO long-term extension t

ViiV Healthcare announced that the US Food and Drug Administration (FDA) approvedApretude, the first

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S.

Berlin, Germany, July 21, 2021– The European Commission has granted marketing authorization in the E

AstraZeneca'sTagrisso(osimertinib) has been approved in China for the adjuvant treatment of pati